This is the authors' abstract. We don't add key points for this paper.
Progress has been made concerning both the number and quality of epidemiologic prevalence studies in sexual medicine; however, there is a paucity of studies of the incidence of these conditions. Because reliable incidence data are critical for prevention and treatment planning, the design and execution of the incidence trials should become a high priority for the field. In addition, repeated calls for the development of a new systematic and integrated diagnostic system in sexual medicine were also evident, because of the perception by many that the imprecision of our current diagnostic system represents the "rate-limiting step" for the epidemiology of the field. The review suggests that although much has been accomplished in the past 15-20 years, much remains to be done.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Derogatis et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: